Expert lawyer in flotations, fundraising, mergers and acquisitions, investment, corporate restructuring and governance.

Corporate Partner Nick Williams provides corporate and commercial advice to UK and international public and private companies and financial advisory firms. His expertise includes mergers and acquisitions, public takeovers, corporate finance, flotations (Official List/LSE Main Market, AIM and AQSE Growth Market), fundraisings on and off market, joint ventures, corporate governance and funds. His expertise spans a range of sectors, including, in particular, financial services, real estate, healthcare, retail, renewables and natural resources. Much of his work involves international businesses.

Work highlights


Advising Jiangxi Copper (Hong Kong) Investment Company Limited in relation to its US$31,000,000 investment in SolGold plc, the London and TSX-listed resources company.


Acting for Aura Renewable Acquisitions Plc on its admission to the Standard Segment of the Financial Conduct Authority’s Official List and the London Stock Exchange’s Main Market.


Advising an investor on its c. US$265,000,000 investment in an offshore fund and subsequent restructuring of the fund structure.


Acting for Dowgate Capital Limited in its role as corporate adviser and broker to Otaq plc (OTAQ) on a £3.6m fundraising and the admission of OTAQ’s ordinary shares to trading on the Access Segment of the AQSE Growth Market.


Acting for a shareholder in relation to the sale of a company which owned and operated a Formula 1 racing team.


Advising numerous businesses on their AIM IPOs, including Kada Technology Holdings Limited, Financial Payment Systems Limited, Cosmedia Group Holdings Limited, Jetion Holdings Limited, China Medical System Holdings Limited, Green & Smart Holdings plc, Pan Pacific Aggregates plc, Yangtze China Investment Limited and Rare Earths Global Limited.


Advising Greenlane Renewables Inc., a TSX listed Canadian company on the English law aspects of its spinout from Pressure Technologies plc and concurrent $8.4m financing.


Advising the underwriters on the English law/AIM Rules aspects of an initial public offering by GW Pharmaceuticals plc of American Depository Shares (“ADSs”) on the NASDAQ Global Market to raise $32.7m and a follow on offering by GW Pharmaceuticals plc of ADSs on NASDAQ to raise $101.1m.

overseas sale

Advising the shareholders of a logistics company on its sale to an overseas buyer.


Advising WH Ireland Limited as joint broker to Defenx plc in relation to an offer of convertible bonds and shares raising gross proceeds of £2.99m.


Advising Optiva Securities Limited on its role as broker to Asiamet Resources Limited in a £10m equity fundraising on AIM.


Advising an IFA business on its acquisitions, structuring and general corporate affairs.


Advising Dozens Savings Plc on its £m 5% secured bond programme which was listed on the NEX Exchange Growth Market.

Recent articles


UK Corporate Governance Code – 2024 update: Enhancements and Implications for Businesses

The Economic Crime and Corporate Transparency Act 2023 (the “Act”) aims to deliver a range of reforms to tackle economic crime and improve transparency over corporate entities.



DMH Stallard LLP acts for Chill Brands Group plc in completing its fundraisings

DMH Stallard was legal adviser to Chill Brands Group plc on the fundraisings and publication of the prospectus and liaised with the Financial Conduct Authority



DMH Stallard advises Dowgate Capital Limited on £3.1m equity fundraising

DMH Stallard LLP have advised Dowgate Capital Limited on its role as broker, and SPARK Advisory Partners Limited as nominated adviser, to AIM quoted Belluscura plc (Belluscura) in a c. £3.1 million equity fundraising